Literature DB >> 10590039

Gene transfer by adenovectors.

M Brenner1.   

Abstract

Mesh：

Year:  1999        PMID： 10590039

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Preventing relapse in melanoma.

Authors:  J Stebbing; M Gore
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

Review 2.  Gene therapy to create biological pacemakers.

Authors:  Gerard J J Boink; Jurgen Seppen; Jacques M T de Bakker; Hanno L Tan
Journal:  Med Biol Eng Comput       Date:  2006-10-18       Impact factor: 2.602

Review 3.  Adenoviral vector immunity: its implications and circumvention strategies.

Authors:  Yadvinder S Ahi; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Gene Ther       Date:  2011-08       Impact factor: 4.391

4.  Adeno-associated virus (AAV) Rep protein enhances the generation of a recombinant mini-adenovirus (Ad) utilizing an Ad/AAV hybrid virus.

Authors:  Z Sandalon; D V Gnatenko; W F Bahou; P Hearing
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E.

Authors:  P Ostapchuk; P Hearing
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 6.  Emerging gene and stem cell therapies for the treatment of erectile dysfunction.

Authors:  Ahmed Harraz; Alan W Shindel; Tom F Lue
Journal:  Nat Rev Urol       Date:  2010-02-16       Impact factor: 14.432

7.  Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression during gene therapy.

Authors:  Carol M Bruzzone; John D Belcher; Nathan J Schuld; Kristal A Newman; Julie Vineyard; Julia Nguyen; Chunsheng Chen; Joan D Beckman; Clifford J Steer; Gregory M Vercellotti
Journal:  Transl Res       Date:  2008-11-04       Impact factor: 7.012

Review 8.  Adenoviral vectors for gene therapy.

Authors:  Joanne T Douglas
Journal:  Mol Biotechnol       Date:  2007-05       Impact factor: 2.860

9.  Transcription factor TBX18 promotes adult rat bone mesenchymal stem cell differentiation to biological pacemaker cells.

Authors:  Yanjun Li; Mei Yang; Gege Zhang; Le Li; Bingjie Ye; Congxin Huang; Yanhong Tang
Journal:  Int J Mol Med       Date:  2017-11-16       Impact factor: 4.101

10.  Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.

Authors:  Gaetano Romano
Journal:  ISRN Oncol       Date:  2012-11-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.